These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22008818

  • 1. Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy.
    Liu K, Jiang D, Zhang L, Yao Z, Chen Z, Yu S, Wang X.
    Vaccine; 2012 Apr 19; 30(19):3034-41. PubMed ID: 22008818
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.
    Sánchez-Burgos G, Ramos-Castañeda J, Cedillo-Rivera R, Dumonteil E.
    Virus Res; 2010 Oct 19; 153(1):113-20. PubMed ID: 20638434
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT, Marshall JD, Dorwart MR, Heeke DS, Rao E, Tummala P, Yu L, Cohen GH, Eisenberg RJ, Sloan DD.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28228587
    [Abstract] [Full Text] [Related]

  • 5. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B, Persson J, Thörn K, Nagy E, Harandi AM.
    Vaccine; 2012 Jun 19; 30(29):4361-8. PubMed ID: 22682292
    [Abstract] [Full Text] [Related]

  • 6. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
    Li S, Peng L, Zhao W, Zhong H, Zhang F, Yan Z, Cao H.
    Vaccine; 2011 May 09; 29(20):3695-702. PubMed ID: 21419774
    [Abstract] [Full Text] [Related]

  • 7. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V, Vanderberg A, Wechsler SL, BenMohamed L.
    Invest Ophthalmol Vis Sci; 2007 Oct 09; 48(10):4643-53. PubMed ID: 17898288
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA, Srivastava R, Chentoufi AA, Geertsema R, Thai NT, Dasgupta G, Osorio N, Kalantari M, Nesburn AB, Wechsler SL, BenMohamed L.
    J Virol; 2015 Jul 09; 89(13):6619-32. PubMed ID: 25878105
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M, Petríková M, Zatovicová M, Soláriková L, Kostolanský F, Mucha V, Russ G.
    Acta Virol; 1997 Feb 09; 41(1):5-12. PubMed ID: 9199708
    [Abstract] [Full Text] [Related]

  • 10. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R, Khan AA, Garg S, Syed SA, Furness JN, Vahed H, Pham T, Yu HT, Nesburn AB, BenMohamed L.
    J Virol; 2017 Jan 15; 91(2):. PubMed ID: 27847359
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
    Tarradas J, Monsó M, Muñoz M, Rosell R, Fraile L, Frías MT, Domingo M, Andreu D, Sobrino F, Ganges L.
    Vaccine; 2011 Jun 10; 29(26):4422-9. PubMed ID: 21496472
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT.
    J Immunol; 1995 Jul 01; 155(1):259-65. PubMed ID: 7602102
    [Abstract] [Full Text] [Related]

  • 17. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.
    Çuburu N, Wang K, Goodman KN, Pang YY, Thompson CD, Lowy DR, Cohen JI, Schiller JT.
    J Virol; 2015 Jan 01; 89(1):83-96. PubMed ID: 25320297
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.
    Chentoufi AA, Zhang X, Lamberth K, Dasgupta G, Bettahi I, Nguyen A, Wu M, Zhu X, Mohebbi A, Buus S, Wechsler SL, Nesburn AB, BenMohamed L.
    J Immunol; 2008 Jan 01; 180(1):426-37. PubMed ID: 18097044
    [Abstract] [Full Text] [Related]

  • 20. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
    Srivastava R, Khan AA, Spencer D, Vahed H, Lopes PP, Thai NT, Wang C, Pham TT, Huang J, Scarfone VM, Nesburn AB, Wechsler SL, BenMohamed L.
    J Immunol; 2015 Mar 01; 194(5):2232-48. PubMed ID: 25617474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.